Fig. 2. qRT-PCR analysis of FLT3 mRNA expression levels in MOLM-14 cells. Cells were treated with different concentrations of gilteritinib for 24 h. Results are expressed as mean ± SEM of three independent experiments.

Biomolecules & Therapeutics 2024;32:577~581 https://doi.org/10.4062/biomolther.2023.215

© Biomolecules & Therapeutics